Hugh S Mason

This inventor holds 23 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Arizona State University, Boyce Thompson Institute for Plant Research, Dow Agrosciences LLC. Active years: 2001-2026.

USPTO Granted Patents = 23 (Patent Applications = 7)

% Patents Active = 91.3

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 140(Granted Patents)

Location History:

Ithaca, NY (US) (2001 - 2009)
Phoenix, NY (US) (2009)
Phoenix, AZ (US) (2006 - 2024)

Company Filing History:

13 out of 2,154

Arizona State University

patents

7 out of 69

Boyce Thompson Institute for Plant Research

Health Research, Inc.

patents

5. 1 out of 1,326

Texas A&M University System

patents

6. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12706176 - Methods, systems, and computer readable media for generating codon optimized nucleotide sequences (2026-08-11),

2. 12297443 - Optimized plant expression systems (2025-05-13),

3. 12286636 - Replicating and non-replicating vectors for recombinant protein production in plants and method of use thereof (2025-04-29),

4. 12257302 - Universal vaccine platform (2025-03-25),

5. 11865174 - Universal vaccine platform (2024-01-09),

6. 11857613 - Vaccine for prevention of necrotic enteritis in poultry (2024-01-02),

7. 11564981 - Vaccine for prevention of necrotic enteritis in poultry (2023-01-31),

8. 11154606 - Vaccine for prevention of necrotic enteritis in poultry (2021-10-26),

9. 11058766 - Universal vaccine platform (2021-07-13),

10. 10125373 - Geminiviral vector for expression of rituximab (2018-11-13),

11. 10080799 - Methods and compositions related to glycoprotein-immunoglobulin fusions (2018-09-25),

12. 9506079 - DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants (2016-11-29),

13. 8513397 - DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants (2013-08-20),

14. 7879338 - Vectors and methods for immunization against norovirus using transgenic plants (2011-02-01),

15. 7572466 - Oral immunology using plant product containing a non-enteric pathogen antigen (2009-08-11),

Title: The Innovative Journey of Hugh S. Mason

Introduction

Hugh S. Mason, an accomplished inventor based in Ithaca, NY, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 20 patents, Mason stands out for his pioneering work, particularly in the development of vaccine technologies. His research and inventions continue to influence the medical community and provide new avenues for combating infectious diseases.

Latest Patents

Among his notable inventions is the Universal Vaccine Platform, which aims to create effective vaccination compositions against various viruses, including human papillomavirus, Zika virus, and influenza. The patent encompasses vectors designed for producing virus-like particles and immune complex platforms that enhance the efficacy of these vaccination compositions. This innovation holds promise for widespread immunization efforts and reflects Mason’s commitment to improving global health.

Career Highlights

Hugh S. Mason's career is highlighted by his tenure at prominent research institutions, including Arizona State University and the Boyce Thompson Institute for Plant Research. His academic and professional experiences have equipped him with a robust understanding of the intersection between biotechnology and patent law, fostering his success as an inventor.

Collaborations

Throughout his career, Mason has collaborated with esteemed colleagues such as Charles Joel Arntzen and Andrew Diamos. These partnerships have not only enriched his research efforts but have also facilitated the sharing of knowledge and expertise within the scientific community, driving forward innovation in vaccine development.

Conclusion

In summary, Hugh S. Mason's contributions to the field of vaccine technology through his innovative patents have established him as a leading figure in biotechnology. His work paves the way for future advancements in vaccination and public health, underscoring the importance of innovation in overcoming global health challenges.